The Marqués de Valdecilla Research Institute (IDIVAL) is strengthening its commitment to healthcare innovation with a new project aimed at transforming the treatment of chronic and surgical wounds, one of the main challenges faced by healthcare systems worldwide.
Through its DTEC-VAL technology development support program, IDIVAL funds initiatives with the potential to generate a real impact on healthcare. In this edition, one of the projects selected is led by Dr. Federico Castillo Suescun, a surgery specialist, who is working on the design of a next-generation dressing with significant clinical and economic potential.
A global challenge with major impact
Chronic wounds, such as pressure ulcers or those associated with diseases like diabetes, affect millions of patients around the world. Their treatment not only entails a high economic cost but also requires a substantial care effort. It is estimated that they occupy a large portion of nurses’ time in primary care and significantly affect the quality of life of those who suffer from them.
In this context, technological innovation emerges as a key tool. New solutions in wound care not only accelerate healing and reduce complications, but also improve the efficiency of healthcare systems and free up resources that can be allocated to other care needs.
An innovation with future potential
The project led by Dr. Castillo proposes a dressing with an innovative design aimed at overcoming the limitations of current products. Its goal is to promote faster, more effective healing, reduce the risk of infections, and optimize the workload of healthcare professionals.
Beyond its healthcare potential, the initiative is protected by patents and has attracted the interest of leading companies in the sector, strengthening its prospects of reaching the market in the near future. Its development is also accompanied by the creation of a spin-off that will facilitate the transfer of this technology into clinical practice.
